Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Boyer

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
International Clinical Psychopharmacology|January 1, 1993
A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorderW F Boyer, J P Feighner
The Mount Sinai Journal of Medicine, New York|March 1, 1989
An overview of fluoxetine, a new serotonin-specific antidepressantW F Boyer, J P Feighner
Psychopathology|January 1, 1989
Serotonin-1A anxiolytics: an overviewJ P Feighner, W F Boyer
The Journal of Clinical Psychiatry|February 1, 1992
An overview of paroxetineW F Boyer, J P Feighner
Journal of Clinical Psychopharmacology|April 1, 1984
What desipramine plasma levels are therapeutic?W F Boyer, C R Lake
The American Journal of Psychiatry|February 1, 1983
Interaction of phenelzine and sulfisoxazoleW F Boyer, C R Lake
Journal of Clinical Psychopharmacology|June 1, 1987
Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactionsW F Boyer, N H Bakalar, C R Lake
The British Journal of Psychiatry. Supplement|September 1, 1988
An overview of fluoxetine in geriatric depressionJ P Feighner, W F Boyer, C H Meredith, et al.
International Clinical Psychopharmacology|July 1, 1989
A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depressionJ P Feighner, W F Boyer, C H Meredith, et al.
The Journal of Clinical Psychiatry|June 1, 1990
Adverse consequences of fluoxetine-MAOI combination therapyJ P Feighner, W F Boyer, D L Tyler, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
International Clinical Psychopharmacology|January 1, 1993
A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorderW F Boyer, J P Feighner
The Mount Sinai Journal of Medicine, New York|March 1, 1989
An overview of fluoxetine, a new serotonin-specific antidepressantW F Boyer, J P Feighner
Psychopathology|January 1, 1989
Serotonin-1A anxiolytics: an overviewJ P Feighner, W F Boyer
The Journal of Clinical Psychiatry|February 1, 1992
An overview of paroxetineW F Boyer, J P Feighner
Journal of Clinical Psychopharmacology|April 1, 1984
What desipramine plasma levels are therapeutic?W F Boyer, C R Lake
The American Journal of Psychiatry|February 1, 1983
Interaction of phenelzine and sulfisoxazoleW F Boyer, C R Lake
Journal of Clinical Psychopharmacology|June 1, 1987
Anticholinergic prophylaxis of acute haloperidol-induced acute dystonic reactionsW F Boyer, N H Bakalar, C R Lake
The British Journal of Psychiatry. Supplement|September 1, 1988
An overview of fluoxetine in geriatric depressionJ P Feighner, W F Boyer, C H Meredith, et al.
International Clinical Psychopharmacology|July 1, 1989
A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depressionJ P Feighner, W F Boyer, C H Meredith, et al.
The Journal of Clinical Psychiatry|June 1, 1990
Adverse consequences of fluoxetine-MAOI combination therapyJ P Feighner, W F Boyer, D L Tyler, et al.
Pageof 3